• Blog
• Rss Feed
• Contact Us

Financing Entrepreneurial Excellence

• About ESP
• Our People
• Portfolio
• News & Events
• Working with Us
• For LPs
• Newsletters

Site Map

Below is a map of the ESP Web site pages.

• Home
  • About ESP
  • Our People
    • Jim Petras
    • Jonathan Murray
    • Mike Bunker
    • Richard Stuebi
    • Andrew McColm
    • Charlie MacMillan
  • Portfolio
    • Healthcare Technologies
    • Information Technology
    • Advanced Manufacturing and Industrial Technologies
    • Alphabetical
      • Amplifinity
      • Arisdyne
      • Axiomed
      • Ayalogic
      • BlueSpark Technologies
      • Cardiox
      • Cleveland Medical Polymers
      • CytoPherx
      • EcoSmart
      • Gensyn
      • Five Star Technologies
      • Great Lakes Pharmaceuticals
      • HealthSpot
      • HistoSonics
      • Imalux
      • Intelligent Clearing Network (ICN)
      • LineStream
      • Juventas Therapeutics
      • MAR Systems
      • NineSigma
      • OnShift
      • Ovation Polymers (OPTEM)
      • Reverse Medical Corporation
      • Simbionix
      • SironRX
      • TOA Technologies
      • Unitask
  • News & Events
    • SironRX Completes Enrollment in Phase I Clinical Trial
    • Telefonica Chooses TOA As Worldwide Partner
    • TOA Technologies Featured in Crain's Cleveland Business
    • ICN Issued Patent to Validate and Clear Coupons Electronically
    • TOA Technologies Named Forbes Most Promising Company
    • Amplifinity First to Receive Pure Michigan Venture Match Fund Investment
    • Unitask Announces Desktop Printing for Oracle EBS
    • TOA Technologies Named One of Top SaaS Companies by Montclair Advisors
    • Axiomed Raises $3.6 Million Series D Extension
    • Eric Williams Joins ICN Board of Directors
    • TOA Technologies Honored For Its Fast International Growth
    • Amplifinity Wins Word of Mouth Marketing Award
    • Simulation Training Saves Lives in Battlefield Surgery
    • CytoPherx Named "Deal of the Year" by MVCA
    • Unitask Hires Alan Bitterman to Lead Development
    • TOA Technologies Named "Leader" in Gartner Magic Quadrant
    • Amplifinity Closes $1.5 Million Early Stage Capital Investment
    • Surgeons Practice Procedures Using Simbionix Simulators
    • TOA Launches ETAworkforce on Force.com
    • TOA Hires Finance Veteran Brian Cook As CFO
    • Juventas Therapeutics Closes $22.2 Million Venture Capital Round
    • SironRx Hires Evan Facher as CEO
    • ICN Signs Blue Chip Advisory Board
    • Axiomed Expands Series D to $20 Million
    • Social Media Comes To Field Work Forces Via TOA Technologies
    • AxioMed Receives CE Mark for Freedom® Cervical Disc
    • TOA Technologies Integrates With SAP
    • Arisdyne Systems Receives Ethanol Processing Patent
    • MAR Systems Receive Cleantech Innovation Award
    • LineStream Closes $5 Million Series B Early Stage Venture Capital Round
    • Juventas Therapeutics Closes $12 Million Early Stage Capital Round
    • OnShift Closes $3 Million Series B Early Stage Capital Investment
    • OnShift Scores In Customer Ratings Survey
    • CytoPherx Raises $34 Million Early Stage Venture Capital Round
    • Amplifinity Raises Series A Early Stage Venture Capital Round
    • Cost of Waiting For Service Calls is $37.7 Billion Annually
    • CardiOx Raises $8 Million Series C
    • SironRx Raises $3.4 Million Early Stage Venture Capital Round
    • Imalux Hires Former Philips Executive Jim Fulton as President and COO
    • UK Retailer Selects TOA Technologies for Home Appointment Scheduling
    • Imalux Wins Third Frontier Grant To Accelerate Commercialization
    • LineStream Signs Major Licensing Deal with Texas Instruments
    • LineStream Releases InTAC Tuning and Control Technology
    • TOA Closes $17.2 Million Series D Led by Sutter Hill Ventures
    • Ensign Picks OnShift Staff Scheduling Solution
    • Reverse Medical Receives FDA Clearance for Intracranial Catheter
    • BlueSpark Hires Industry Veteran Norbert Dawalibi as New CEO
    • ICN Closes Early Stage Venture Capital Funding Round
    • Juventas Therapeutics Cleared to Begin Phase II Clinical Trial
    • OnShift Secures Additional Series A Funding
    • TOA Technologies Wins Weatherhead 100 Award
    • Wall Street Journal Praises Cleveland's Early Stage Community
    • TOA Hires Bruce Grainger as Sr. VP Americas
    • von Eschenbach Joins Histosonics Board
    • Automation Alley Invests in Unitask
    • Simbionix Relocates Education Division to Cleveland
    • Simbionix Expands Facilities in U.S. and Israel
    • Great Lakes Pharmaceuticals Raises Series B Early Stage Venture Capital Round
    • Axiomed Spine Closes $14.5 Million Series D
    • TOA Named to Gartner "Visionaries" Quadrant
    • MAR Systems Receives BlueTech Award
    • Simbionix Receives BIRD Grant to Develop Hysterectomy Simulation
    • ICN Launches SaaS Clearing Network for Paper Coupons
    • Virgin Media Rolls Out TOA Software
    • Ovation Polymer Launches Medical Polymers Company
    • Simbionix Launches Mobile App For Handhelds
    • Reverse Medical Corp. Closes $14 Million Series B
    • BusinessWeek Names MAR Systems "Most Promising"
    • TOA Hires Richard Alden as EU President
    • EcoSmart Broadens Footprint in Home Depot
    • HistoSonics Secures $11 Million Series A Early Stage Venture Capital Funding
    • Unitask Grows Revenue 25% in 2009
    • Five Star Wins $1 Million Photovoltaics Grant
    • Surgeons Improve Outcomes with Simbionix' Rehearsal Studio
    • MAR Systems Receives Series B Investment
    • OnShift Receives Series A Early Stage Venture Capital Investment
    • Andy McColm to Staff Michigan Office
    • Blue Spark Receives Series B Financing
    • Blue Spark CEO Appears on CNBC
    • TOA Partners with Amdocs
    • Axiomed Receives CE Mark for Freedom® Lumbar Disc
    • Imalux Differentiates Grades of Cervical Dysplasia
    • ACelleRX Closes Series A Financing
    • Simbionix Closes Series C Financing
    • LineStream Technologies Closes Series A Investment
    • Stuebi To Join ESP
    • Arisdyne Systems Installs Biodiesel Reaction
    • New Solar Inks from Five Star Technologies Bring Higher Level of Consistency to Silicon Cells
    • Axiomed Spine Initiates Pivotal Clinical Trial
    • TOA Awarded Gartner Most Innovative CRM Company Award
    • TOA Technologies Closes $13 Million Series C
    • Imalux Receives $2.3 Million Fast-Track Grant from NIH
    • Simbionix Medical Simulator Receives FDA Clearance
    • Juventas Lead Compound Successfully Completes Phase I Trial
    • Reverse Medical Sells Neurovascular Guide Catheter Business
    • Axomed Achieves "First in Man" for Freedom Cervical Disc
  • Working with Us
  • For LPs
  • Newsletters
    • ESP Newsletter: Issue 5
    • ESP Newsletter: Issue 4
    • ESP Newsletter: Issue 1
    • ESP Newsletter: Issue 2
    • ESP Newsletter: Issue 3
• Contact ESP
• Privacy Policy
• Site Map
• Footer
  • Home
  • Contact ESP
  • Privacy Policy
  • Site Map
• Subscribe to Our Newsletter

• Home
• Contact ESP
• Privacy Policy
• Site Map

Early Stage Partners | 1801 East 9th Street, Suite 1700 | Cleveland, Ohio 44114 | Phone: 216.781.4600
Designed & Developed by: MindStreams